This was the stock's second consecutive day of losses.

Shares of Catalyst Pharmaceuticals Inc. CPRX shed 1.43% to $24.11 Thursday, on what proved to be an all-around grim trading ...

Renaissance Investment Management, an investment management company, released its Q4 2024 “Small Cap Growth Strategy” investor letter. A copy of the letter can be downloaded here. The Russell 2000 ...

Catalyst Pharmaceuticals Stock Performance Catalyst Pharmaceuticals stock opened at $24.46 on Thursday. The firm has a market cap of $2.97 billion, a price-to-earnings ratio of 20.73, a price-to ...

A major breakthrough in liquid catalysis is transforming how essential products are made, making the chemical manufacturing ...

We recently published a list of Jim Cramer Discussed These 6 Stocks Recently. In this article, we are going to take a look at ...

Catalyst Pharmaceuticals Trading Down 0.6 % Shares of CPRX opened at $24.69 on Friday. Catalyst Pharmaceuticals, Inc. has a twelve month low of $14.47 and a twelve month high of $26.16. The firm ...

In its fourth quarter 2024 investor letter, Renaissance Investment Management Small Cap Growth Strategy emphasized stocks such as Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX). Catalyst ...

As predicted by many analysts, economists, and investors, the sweeping tariffs announced by the Trump administration on Wednesday decimated the stock market on Thursday. It had one of its worst ...

Supernus Pharmaceuticals got a positive adjustment to its Relative Strength (RS) Rating, from 67 to 81. Please watch the ...